Dashboard
Manage Tickers

ARCC ARES CAPITAL CORP

Nasdaq arescapitalcorp.com


$ 19.99 $ 0.45 (2.31 %)    

Tuesday, 14-Oct-2025 19:45:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 19.94
$ 19.32
$ 19.90 x 10
$ 20.00 x 858
$ 19.29 - $ 20.00
$ 17.48 - $ 22.91
7,221,837
na
14.07B
$ 0.70
$ 10.40
TBD
na
na ($ 0.10)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-29-2025 06-30-2025 10-Q
2 04-29-2025 03-31-2025 10-Q
3 02-05-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 07-30-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-07-2024 12-31-2023 10-K
8 10-23-2023 09-30-2023 10-Q
9 07-25-2023 06-30-2023 10-Q
10 04-25-2023 03-31-2023 10-Q
11 02-07-2023 12-31-2022 10-K
12 10-25-2022 09-30-2022 10-Q
13 07-26-2022 06-30-2022 10-Q
14 04-26-2022 03-31-2022 10-Q
15 02-09-2022 12-31-2021 10-K
16 10-26-2021 09-30-2021 10-Q
17 07-28-2021 06-30-2021 10-Q
18 04-28-2021 03-31-2021 10-Q
19 02-10-2021 12-31-2020 10-K
20 10-27-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 02-12-2020 12-31-2019 10-K
24 10-30-2019 09-30-2019 10-Q
25 07-30-2019 06-30-2019 10-Q
26 04-30-2019 03-31-2019 10-Q
27 02-12-2019 12-31-2018 10-K
28 10-31-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-13-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 02-22-2017 12-31-2016 10-K
36 11-02-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-24-2016 12-31-2015 10-K
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ubs-maintains-neutral-on-ares-capital-lowers-price-target-to-21
UBS Maintains Neutral on Ares Capital, Low...
10/14/2025 16:21:14

UBS analyst Doug Harter maintains Ares Capital (NASDAQ:ARCC) with a Neutral and lowers the price target from $22.5 to $21.

what-7-analyst-ratings-have-to-say-about-ares-capital
What 7 Analyst Ratings Have To Say About A...
10/10/2025 20:01:07

lucid-capital-markets-initiates-coverage-on-ares-capital-with-buy-rating-announces-price-target-of-225
LUCID CAPITAL MARKETS Initiates Coverage O...
10/10/2025 17:10:03

LUCID CAPITAL MARKETS analyst Ethan Kaye initiates coverage on Ares Capital (NASDAQ:ARCC) with a Buy rating and announces Pr...

whats-driving-the-market-sentiment-around-ares-capital-corp
What's Driving the Market Sentiment Around...
10/02/2025 15:01:01

top-3-financial-stocks-youll-regret-missing-in-q3
Top 3 Financial Stocks You'll Regret Missi...
09/18/2025 10:32:39

5-regional-bank-stocks-exploding-higher
5 Regional Bank Stocks Exploding Higher
08/26/2025 11:36:00

Regional banks MBCN, PVBC, UBCP, NKSH, and FVCB surge in quality rankings, signaling strong financial health. Explore opportuni...

3-income-stocks-the-best-in-the-business-are-buying-now
3 Income Stocks The Best In The Business A...
08/15/2025 19:16:18

jmp-securities-maintains-market-outperform-on-ares-capital-raises-price-target-to-23
JMP Securities Maintains Market Outperform...
07/31/2025 15:00:12

JMP Securities analyst Brian McKenna maintains Ares Capital (NASDAQ:ARCC) with a Market Outperform and raises the price targ...

wells-fargo-maintains-overweight-on-ares-capital-raises-price-target-to-23
Wells Fargo Maintains Overweight on Ares C...
07/30/2025 13:57:48

Wells Fargo analyst Finian O'Shea maintains Ares Capital (NASDAQ:ARCC) with a Overweight and raises the price target fro...

keefe-bruyette--woods-maintains-outperform-on-ares-capital-raises-price-target-to-23
Keefe, Bruyette & Woods Maintains Outperfo...
07/30/2025 12:34:25

Keefe, Bruyette & Woods analyst Paul Johnson maintains Ares Capital (NASDAQ:ARCC) with a Outperform and raises the price...

b-riley-securities-upgrades-ares-capital-to-buy-raises-price-target-to-235
B. Riley Securities Upgrades Ares Capital ...
07/30/2025 11:41:37

B. Riley Securities analyst Bryce Rowe upgrades Ares Capital (NASDAQ:ARCC) from Neutral to Buy and raises the price target f...

ares-capital-q2-adj-eps-050-misses-051-estimate-total-investment-income-745000m-miss-753483m-estimate
Ares Capital Q2 Adj. EPS $0.50 Misses $0.5...
07/29/2025 10:08:00

Ares Capital (NASDAQ:ARCC) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.51 ...

Core News & Articles
Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

the-analyst-verdict-ares-capital-in-the-eyes-of-6-experts
The Analyst Verdict: Ares Capital In The E...
07/16/2025 21:03:29

ubs-maintains-neutral-on-ares-capital-raises-price-target-to-225
UBS Maintains Neutral on Ares Capital, Rai...
07/16/2025 15:12:05

UBS analyst Doug Harter maintains Ares Capital (NASDAQ:ARCC) with a Neutral and raises the price target from $22 to $22.5.

warren-buffetts-quiet-dividend-play-9-high-yield-stocks-held-by-a-berkshire-subsidiary
Warren Buffett's Quiet Dividend Play: 9 Hi...
07/09/2025 08:53:16

Warren Buffett is indirectly invested in high-dividend yield stocks via Berkshire Hathaway Inc.'s subsidiary New England As...

what-analysts-are-saying-about-ares-capital-stock
What Analysts Are Saying About Ares Capita...
06/27/2025 14:00:29

wells-fargo-maintains-overweight-on-ares-capital-raises-price-target-to-22
Wells Fargo Maintains Overweight on Ares C...
06/27/2025 13:11:49

Wells Fargo analyst Finian O'Shea maintains Ares Capital (NASDAQ:ARCC) with a Overweight and raises the price target fro...

pe-ratio-insights-for-ares-capital
P/E Ratio Insights for Ares Capital
06/04/2025 18:00:26

ares-capital-prices-public-offering-of-750m-in-aggregate-principal-amount-of-5500-notes-due-2030
Ares Capital Prices Public Offering of $75...
05/27/2025 21:27:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION